Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KRN321 in pediatric patients with chronic kidney disease
jRCT2080221341Phase 3
- Sponsor
- Kyowa Kirin
- Start
- Dec 2010
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of darbepoetin alfa in chronic kidney disease (CKD) and anaemia, sponsored by Kyowa Kirin.
02
Drugs
darbepoetin alfa
03
Conditions
chronic kidney disease (CKD)anaemia
Beyond the preview
Go deeper on jRCT2080221341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221341.